The contract was concluded in 2001. Tanabe Mitsubishi acquired registration of recombinant albumin in 2007, but recognition was withdrawn in 2009 following clinical trials. Since then, bulk supply for research was also stopped. All stocks held by Nypro in Bipha Co. are transferred to Tanabe Mitsubishi

Nipro press release, August 31, 2012